Multiple system atrophy and Parkinson’s disease are progressive nervous system disorders that affect everyday movements. Multiple system atrophy is rarer and tends to progress more quickly.

An experimental therapy for Parkinson's disease being developed by Roche and Prothena has missed the mark in a phase 2b trial ...

Patients also may develop hoarseness, difficulty breathing due to vocal cord weakness, and frequent involuntary sighing. Initial symptoms of MSA overlap with those of Parkinson's disease and many ...

Dr. Charles Ide, Western Michigan University Gwen Frostic Professor of Biological Sciences and Director of the Great Lakes Environmental and Molecular Sciences Center, has been researching a deadly ...

MSA is divided into MSA-C (cerebellar type) which has more symptoms of ataxia (incoordination) and MSA-P (parkinsonian type) which has more parkinsonian symptoms but is relatively unresponsive to the ...

AC Immune SA has divulged compounds acting as α-synuclein (SNCA) aggregation inhibitors reported to be useful for the treatment of multiple system atrophy (MSA), Parkinson’s dementia, Lewy body ...

Researchers wanted to see if mapping the structural and functional connections across the brain could be used to predict patterns of atrophy spread in patients with mild Parkinson's disease. They ...